Business Development Deal Architecture
  • Search OnBioBD:

  • OnBioBD OldSkool NEWS:

    - OnBioVC 4Q11 Trend Analysis, now available
    - OnBioVC 1Q12 White Paper, now available
    - OnBioVC 1Q12 Trend Analysis, coming soon

  • FDA Registered Contract Manufacturer

Cardioxyl Pharmaceuticals (Chapel Hill, NC), a clinical stage pharmaceutical company utilizing its proprietary nitroxyl chemistry platform to discover and develop novel therapeutics to treat cardiovascular disease, closed a $28M Series B financing. Participants include OrbiMed Advisors, Osage University Partners, New Enterprise Associates and The Aurora Funds.

Applied Genetic Technologies (Gainesville, FL), a clinical-stage biotechnology company focused on respiratory and retinal diseases, closed a $37.5M Series B financing. Participants include Alta Partners, S.R. One, Osage University Partners, InterWest Partners, Intersouth Partners and MedImmune Ventures. Collective IP | The World’s Largest Technology Transfer Office Marketplace Providing Unrivaled Comprehensive and Accurate Access to Humankinds […]

Heat Biologics (Chapel Hill, NC) a clinical-stage biopharmaceutical company focused on vaccines and antibodies for non-small cell lung cancer and stimulation of regulatory T cells, closed a $2.8M Series A financing. Participants include Brightline Ventures.

Atlanta Catheter Therapies (Chattanooga, TN) a development-stage medical device company focused on catheter technologies for vascular disease, closed a $2.9M Series A financing. Participants were not identified.

simplifyMD (Alpharetta, GA) a commercial-stage electronic health records company, closed a $4.5M Series A financing. Participants include Intersouth Partners.

CeNeRx (Cary, NC) a clinical-stage biopharmaceutical company focused on diseases of the central nervous system, depression and anxiety, closed a $4.6M Series D financing. Participants include Aisling Capital, L Capital Partners, Perseus Soros Biopharmaceutical Fund, Omega Funds and Pappas Ventures.

Breathe America (Nashville, TN) a commercial-stage clinical company focused on the treatment of chronic airway diseases, allergy, sinus and asthma, closed a $22M Series B financing. Participants include Essex Woodlands. Thanx for your patience as we catch-up.

Embera NeuroTherapeutics (Shreveport, LA) a development stage pharmaceutical company focused on treatments for smoking cessation and other addictions, closed a $4.5M Series A financing. Participants include Louisiana Ventures, Louisiana Fund and Themelios Ventures. Thanx for your patience as we catch-up.

Metabolon (Durham, NC) a commercial-stage provider of biomarker discovery and analysis, closed a $13.1M Series D financing. Participants include Keating Capital, Sevin Rosen Funds, Aurora Funds, Harris & Harris Group, Syngenta Ventures and Fletcher Spaght.

Clinipace Worldwide (Durham, NC) a commercial-stage global digital clinical research organization specializing in strategic product and clinical development, closed a $15M Series C financing. Participants include Morgan Stanley, Hatteras Venture Partners and Brook Private Equity Advisors. The 3Q11 OnBioVC Trend Analysis Will Be Available Next Monday 31 October

CareCloud (Miami, FL) a commercial-stage developer provider of cloud-based healthcare management software, closed a $20.1M Series A financing. Participants include Intel Capital and Norwest Venture Partners.

Esperance Pharmaceuticals (Baton Rouge, LA) a clinical-stage oncology and companion diagnostic company, closed a $7.5M Series B financing. Participants include Sanofi, Louisiana Fund, Themelios Ventures, Research Corporation Technologies and Advantage Capital Partners.

OrthoSensor (Sunrise, FL) a development-stage medical device company focused on remote monitoring of orthopedic implants, closed a $21M Series B financing. Participants include Ziegler Meditech Equity Partners.

« Previous Entries  Next Page »

to top of page...